|8-KJan 30, 9:20 AM ET

Dauch Corp 8-K

Research Summary

AI-generated summary

Updated

Dauch Corp Increases Authorized Shares; Publishes UK Prospectus

What Happened
Dauch Corporation announced it amended its Certificate of Incorporation to increase authorized common shares and published a U.K. prospectus related to its proposed acquisition of Dowlais Group plc. On January 30, 2026 the Company filed the amendment with the Delaware Secretary of State, which became effective on filing. The amendment increases authorized common stock from 150,000,000 to 375,000,000 shares. Also on January 30, 2026, Dauch released a U.K. Prospectus (under the FCA Prospectus Rules) for admission of its shares to the FCA Official List and trading on the London Stock Exchange main market, and issued a Regulatory News Service announcement and a press release providing a Business Combination update.

Key Details

  • Share capital change: authorized common shares increased from 150,000,000 to 375,000,000 (effective Jan 30, 2026).
  • Prior approval: the increase was approved by Dauch stockholders at a special meeting on July 15, 2025.
  • Prospectus & listing steps: U.K. Prospectus prepared under FCA PRM rules for listing in the equity shares (international commercial companies secondary listing) category and trading on the LSE main market.
  • Communications: company published an RNS announcement and a press release on Jan 30, 2026 updating the market on the Business Combination.

Why It Matters
The authorized-share increase creates capacity for issuing additional Dauch shares, which is a practical step toward completing the proposed merger with Dowlais (for example, to issue shares as merger consideration or for financing). Publication of the U.K. Prospectus and related RNS/press release are required steps toward admitting Dauch’s shares to the FCA Official List and trading on the London Stock Exchange—key milestones in progressing the previously announced Business Combination. Investors should note these are procedural and do not guarantee completion of the transaction; the filing also includes the company’s standard forward-looking statement caution.